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Differential Requirements for Runx Proteins in
CD4 Repression and Epigenetic Silencing
during T Lymphocyte Development
as well as the heritable repression of genes. Stable si-
lencing of specific genes is thought to be mediated
through establishment of heterochromatin, which then
allows maintenance of the repressed state through epi-
genetic mechanisms (Fisher and Merkenschlager, 2002;
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et al., 2002; Zou et al., 2001). This provides a unique
T lymphocytes differentiate in discrete stages within opportunity to characterize the factors involved in estab-
the thymus. Immature thymocytes lacking CD4 and lishment of epigenetic silencing and elucidate their
CD8 coreceptors differentiate into double-positive mechanism of action. The CD4 gene encodes a corecep-
cells (CD4CD8), which are selected to become either tor molecule that plays a pivotal role during thymocyte
CD4CD8helper cells or CD4CD8 cytotoxic cells. differentiation by interacting with MHC class II mole-
A stage-specific transcriptional silencer regulates ex- cules together with the  T cell antigen receptors
pression of CD4 in both immature and CD4CD8 thy- (TCRs) (Killeen and Littman, 1996). Early T lymphocyte
mocytes. We show here that binding sites for Runt progenitors do not express either CD4 or the CD8 core-
domain transcription factors are essential for CD4 si- ceptor and are termed double-negative (DN) thymo-
lencer function at both stages, and that different Runx cytes. DN cells that undergo in-frame rearrangements
family members are required to fulfill unique functions of their TCR genes express a functional pre-TCR com-
at each stage. Runx1 is required for active repression plex, which permits selection (termed  selection) to the
in CD4CD8 thymocytes whereas Runx3 is required next developmental stage, during which both CD4 and
for establishing epigenetic silencing in cytotoxic lin- CD8 are expressed and the TCR loci undergo re-
eage thymocytes. Runx3-deficient cytotoxic T cells, arrangement (Groettrup and von Boehmer, 1993). The
but not helper cells, have defective responses to anti- CD4CD8 (double-positive or DP) thymocytes then un-
gen, suggesting that Runx proteins have critical func- dergo positive selection if their TCR molecules inter-
tions in lineage specification and homeostasis of CD8- act productively with MHC class I or class II molecules
lineage T lymphocytes. complexed to self-peptides, and they differentiate into
two functionally different lineages of T lymphocytes, the
Introduction CD4CD8 helper cells and the CD4CD8 cytotoxic T
cells (von Boehmer et al., 1989). CD4-lineage T cells
Determination of specific cell fates during development generally interact with MHC class II, while CD8-lineage
of multicellular organisms is dependent on the activation cells interact with MHC class I. The mechanism by which
the specificity of TCR for MHC is translated into the
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The CD8 and CD8 genes are regulated by multiple of RUNX1/AML1 have been identified in acute myeloid
dispersed enhancer elements that function in concert to leukemia patients (Miyoshi et al., 1991; Osato et al.,
provide stage-specific expression (Ellmeier et al., 1999; 1999), and mutations of RUNX2/CBFA1 have been dem-
Hedrick, 2002). In contrast, CD4 is regulated by a combi- onstrated in cleidocranial dysplasia (CCD) patients
nation of an enhancer, that is active at all stages of T (Mundlos et al., 1997). Recently, mutations of RUNX3
cell development, and a silencer, that represses expres- have been linked with gastric cancer (Li et al., 2002).
sion in immature DN and in mature CD8 cytotoxic lin- Thus, abnormalities in RUNX genes are potentially in-
eage T cells (Ellmeier et al., 1999; Sawada et al., 1994; Siu volved in human diseases. Genetic approaches in Dro-
et al., 1994). Targeted mutagenesis of the CD4 silencer in sophila have revealed that Runx functions both to acti-
mice has shown that it is required for repression of vate and to repress transcription of different target
CD4 expression in both DN and mature CD8-lineage genes in a context-dependent manner (Canon and Ban-
thymocytes (Leung et al., 2001; Zou et al., 2001). Silenc- erjee, 2000). However, little is known about the molecu-
ing of the CD4 locus was unaffected in mature CD8 T lar mechanisms through which Runx proteins regulate,
lymphocytes if the silencer was deleted after completion and in particular repress, gene expression.
of intrathymic differentiation, indicating that silencing is In this report, we show essential roles of the Runt
epigenetically maintained in these cells (Zou et al., 2001). domain binding sites within the CD4 silencer and of
Several motifs required for silencer function in both DN Runx transcription factors in CD4 silencing. By using
and CD8-lineage thymocytes have been identified by mutational analyses in mice, distinct requirements for
targeted mutagenesis in mice (Taniuchi et al., 2002). Runx1 and Runx3 were demonstrated at the two stages
Individual mutations resulted in variegated derepression of development at which the CD4 silencer is active. Runx
of CD4 in mature CD8 T cells. This resembled position 1 was shown to be required to repress CD4 expression
effect variegation (PEV) of transgene expression, a well- in DN thymocytes, while Runx3 was shown to be re-
characterized inhibitory effect of heterochromatin (Wak- quired both for establishment of epigenetic silencing
imoto, 1998). The overexpression of HP-1, an evolution- and for specification of functional cytotoxic T cells. The
arily conserved molecule that enhances the silencing results provide a key link between sequence-specific
effect of heterochromatin, also enhanced CD4 silencing transcription factors and the function of a specific devel-
in mutant mice with variegated CD4 derepression (Tani- opmentally regulated silencer, and identify an important
uchi et al., 2002). These results reinforce the conclusion in vivo target for members of the Runx family.
that the CD4 locus is silenced in cytotoxic-lineage T
cells through an epigenetic maintenance mechanism. In Results
immature DN thymocytes, mutations resulted in uniform
partial derepression of CD4, which suggested that there Runx Binding Sites Are Required for CD4 Silencing
could be different mechanisms of silencing operating at In Vivo
the two developmental stages at which CD4 is repressed In earlier studies combining analyses in transfected cells
(Taniuchi et al., 2002). and in gene-targeted mice, we identified several func-
On the basis of studies in transgenic mice and trans-
tionally important sites within the 434 bp CD4 silencer.
fected cell lines, several other putative functional sites
We focused, in particular, on a core sequence (131–265)
within the CD4 silencer have been reported, along with
that conferred strong inhibitory activity in transient
potential binding factors, including HES-1, SAF (silencer
transfection assays in the mouse CD4CD8 thymomaassociated factor), and c-Myb (Allen et al., 2001; Donda
1200M (Taniuchi et al., 2002). The core sequence oret al., 1996; Kim and Siu, 1998, 1999). Roles for these
fragments derived from it were used to generate yeastsites and the proposed factors have not been confirmed
reporter strains for screening a library of mouse thymusin vivo, and no physiologically relevant trans-acting fac-
cDNAs fused to a sequence encoding the GAL4 activa-tor required for CD4 silencing has previously been re-
tion domain. This screen resulted in the cloning of aported.
cDNA encoding the Runt domain (1Met-252Pro) of theThe Runt domain transcription factors, Runx, com-
transcription factor Runx1. Two 5-PuACCPuCA-3 con-prise a family of transcriptional regulators that contain
sensus binding motifs for Runt domain factors werea conserved 128 amino acid Runt domain responsible
present in opposite orientation within the core sequencefor sequence-specific DNA binding. Runx proteins make
(Figure 1A). However, mutagenesis analyses showedheterodimeric complexes with a partner protein,
distinct requirements of these two motifs both for si-PEBP2/CBF in mammals and Brother and Big-brother
lencer activity and for binding of trans-acting factors.in Drosophila, and bind to the DNA sequence, 5-PuAC-
One of these motifs (sequence 232GACCACA238), whichCPuCA-3 (Bae and Ito, 1999; Wheeler et al., 2000). Three
we have designated as site 2, is completely required formammalian Runt domain transcription factors, Runx1/
silencer activity in both the transient transfection assayPEBP2B/AML1, Runx2/PEBP2A /CBFA1, and Runx3/
(Figure 1B) and in a transgenic reporter system (SawadaPEBP2C, have been identified. Runx proteins play piv-
et al., 1994) (Supplemental Figure S1 available at http://otal roles in regulating transcription in developmental
www.cell.com/cgi/content/full/111/5/621/DC1), whilepathways ranging from sex determination, eye develop-
another motif (sequence 248TGTGGTG253) is partially re-ment, hematopoiesis, and segmentation in Drosophila
quired in both assays. Further fine mutagenesis analysisto hematopoiesis, bone development, and neurogenesis
indicated that the minimum sequence required for site 2in mice (Canon and Banerjee, 2000; Ducy et al., 1997;
function is identical to the Runx consensus motif (FigureKania et al., 1990; Komori et al., 1997; Lebestky et al.,
1C), whereas the other site required sequences outside2000; Levanon et al., 2002; Okuda et al., 1996; Otto et
al., 1997; Wang et al., 1996; Inoue et al., 2002). Mutations of the consensus binding motif for its function (Figure
Roles of Runx in CD4 Silencing
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Figure 1. Requirement of a Runx Site for CD4
Silencer-Mediated Transcriptional Re-
pression
(A) Alignment of nucleotide sequences from
the mouse and human CD4 silencers and mu-
tations used for reporter constructs are
shown. Underlined sequences represent con-
sensus Runx binding motifs.
(B) Effect of deletions and mutations in the
putative Runx sites within the core CD4 si-
lencer on transcriptional repression in tran-
siently transfected 1200M cells. Three copies
of CD4 silencer fragments (S) were inserted
upstream of the CD4 enhancer (E)/CD4 pro-
moter (P) in a CAT reporter construct. Results
are the average from three separate experi-
ments.
(C). Fine nucleotide sequence mapping of site
2. Transfections were as in (B). Results from
three experiments were averaged with stan-
dard deviations. The underlined sequence,
232GACCACA238, is essential for site 2 function.
(D) Specific binding of a Runt domain to site
2 in yeast. Three copies of each CD4 silencer
fragment were inserted upstream of the mini-
mal promoter (P) in the pLacZi vector. The
fold activation of the reporter gene by the
T-1 plasmid encoding a Runx1 Runt domain
relative to the control plasmid (GAL4-AD only)
was monitored by -galactosidase activity in
each yeast reporter strain.
1B). Consistent with this finding, the Runt domain inter- we had previously observed variegated derepression of
CD4 in CD8-lineage T cells following deletion of se-acted preferentially with site 2 in the yeast one-hybrid
analysis (Figure 1D). quences 1–95 and 1–130 (Taniuchi et al., 2002), we
scanned this region for additional Runx binding motifsTo confirm the physiological importance of the Runx
binding site within the core silencer sequence in CD4 and identified the consensus sequence, 81AACCACA87.
Mutation of this site resulted in derepression of CD4 ingene regulation, we introduced mutations into the CD4
silencer by homologous recombination in ES cells (Tani- about 6% of mature CD8 T lymphocytes. However,
when this site was mutated in combination with site 2uchi et al., 2002) (Figures 2A and 2B). The ES cells were
used to generate chimeric mice, and peripheral T cells in the core silencer sequence, there was full derepres-
sion of CD4 (Figure 2C). We have designated the se-expressing the ES-derived isotype marker Ly9.1 were
analyzed for CD4 and CD8 expression by flow cytometry quence between nucleotides 81–87 as site 2. These
results indicate that sites 2 and 2 have overlapping(Figure 2C). There was no derepression of CD4 in CD8
T lymphocytes from chimeric mice generated with the function and act synergistically to confer full silencing
activity. They also suggest that a transcription factorwild-type construct (Figure 2C). We previously showed
that all mature CD8 T lymphocytes derepressed CD4 that can bind to either sequence is required for CD4
silencing.upon deletion of the entire silencer (sequences 1–429)
or the core sequence (167–257) (Taniuchi et al., 2002). We have previously shown that deletions or point mu-
tations in the CD4 silencer resulted in various degreesMutation of site 2, the Runx binding site, resulted in
variegated derepression of CD4 in 18%–30% of mature of CD4 derepression in immature DN thymocytes (Tani-
uchi et al., 2002; Zou et al., 2001). We therefore analyzedCD8 T lymphocytes (Taniuchi et al., 2002). Because
Cell
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Figure 2. Runx Sites Are Required In Vivo for CD4 Silencing in Mature CD8 T Cells
(A) Strategy for introducing mutations into the Runx sites within the CD4 silencer at the CD4 locus. The targeting vectors were constructed
with 1.8 kb of 5-homology region, a neomycin resistance gene (Neo) flanked by loxP sites (arrow head), a segment containing wild-type or
mutant silencer, and 5 kb of 3-homology region. Mutant sequences at site 2 and site 2’ in constructs 2, 3, and 4 are underlined. The restriction
sites shown are BamHI (B), KpnI (K), NotI (N), SacI (S), and XbaI (Xb).
(B) Southern blot analyses of BamHI-digested ES cell DNA hybridized with the 0.5 kb probe (shown as hatched box).
(C) Flow cytometry analyses of CD4 and CD8 expression on ES cell-derived lymphocytes from chimeric mice. Peripheral lymphocytes derived
from ES cells were identified by gating for surface expression of Ly9.1. The percentage of cells that have derepressed CD4 in the CD8
population is shown in the right top corner.
the effect of the combined site 2 and 2 mutations on Runx Proteins Actively Repress Transcription
in the Context of the CD4 SilencerCD4 expression in a population of Thy1CD8 CD3
TCR thymocytes, which correspond to DN cells. CD4 We used real-time RT-PCR to assess the level of mRNA
expression for each member of the Runx family and forwas also derepressed in these cells, in a uniform, non-
variegated pattern, but its expression level was lower Cbf at different stages of T cell development (Figure
3A). Purity of each T cell subset was monitored by CD4than observed in mice with the nucleotide 1–429 CD4
silencer deletion (see Figure 5A, upper image). Thus, mRNA levels. Transcripts for all three Runx genes and
for Cbf were detected in each thymocyte subset andloss of the two Runx sites in the CD4 silencer resulted
in partial CD4 derepression in DN thymocytes and in full in mature T cells. However, there were marked differ-
ences in levels of expression at each stage, with Runx1CD4 derepression in mature CD8 T lymphocytes.
Roles of Runx in CD4 Silencing
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Figure 3. Expression of Runx Genes during T Cell Development and In Vitro Runx Repressive Activity on the CD4 Silencer
(A) Quantitative real-time PCR of reverse-transcribed RNA from purified thymocyte and T cell subsets. The amount of transcript of the gene
of interest was normalized to the amount of actin RNA in each subpopulation and is shown relative to the amount in immature CD4CD8
thymocytes. DN: CD4CD8 thymocytes; DP: CD4CD8 thymocytes; 4S: CD4CD8 thymocytes; 8S: CD4CD8 thymocytes; 4T: CD48
splenocytes; and 8T: CD4CD8 splenocytes. Results from six to eight PCR reactions with two different sources of RNA were averaged with
standard deviations.
(B) Repression of transcription by Runx fusion proteins in the context of the CD4 silencer. Schematic of the UAS/Runx CAT reporter construct
and GAL4-Runx1 and GAL4-Runx3 fusion proteins. The Runx site (site 2) within the 131–265 core CD4 silencer in the CAT reporter plasmid
(Figure 1B) was replaced with a GAL4 binding site (UAS). Expression vectors encoding the control GAL4 DNA binding domain (GAL4), GAL4-
Runx1 or GAL4-Runx3 were transfected with the UAS/Runx CAT construct into 1200M cells. Results from three transfections were averaged
with standard deviations.
(C) Inhibition of CD4 silencer-mediated transcriptional repression by overexpression of a Runt domain. Expression vectors encoding the Runt
domain (1Met-186Gln) of Runx1 (Runt) or control plasmid (cont.) were transfected with Mut 3-3 CAT (Figure 1B). Results from three transfections
were averaged with standard deviations.
(D) Runx1 and Runx3 restore CD4 silencer-mediated transcriptional repression impaired by Runt domain overexpression. The Mut 3-3 CAT
reporter construct and the expression vector encoding only the Runt domain were cotransfected with expression plasmid encoding wild-type
Runx1 (Runx1), wild-type Runx3 (Runx3), or control empty vector, pcDNA3 (cont.). Results from three transfections were averaged with
standard deviations.
and Runx3 mRNAs most abundant in DN thymocytes the GAL4 DNA binding domain (GAL4-DB) fused with
Runx1 or Runx3 were both shown to repress transcrip-and mature thymocytes, respectively. The level of each
transcription factor did not differ significantly between tion when the GAL4 binding site (UAS) was used to
replace the Runx binding site within the core (131–265)thymocytes and T cells of the helper and cytotoxic lin-
eages. CD4 silencer fragment (Figure 3B). In addition, overex-
pression of the Runt domain (1Met-186Gln) from Runx1To determine whether Runx proteins act as transcrip-
tional activators or repressors in the context of the CD4 resulted in the loss of residual transcriptional repression
mediated by the partial loss of function mutant constructsilencer, we examined their function in the 1200M tran-
sient transfection assay system. Proteins consisting of Mut 3-3 in 1200M cells (Figure 3C). Importantly, expres-
Cell
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sion of full-length Runx1 or Runx3 overcame the effect behaves like the wild-type gene. In thymocytes from
Runx1F/F/Lck-cre mice, more than 95% of the targetedof the Runt domain and restored repression (Figure 3D).
Together, these results indicate that the Runx proteins Runx1 alleles were deleted, allowing for analysis of the
role of this gene in T cell development (Figure 4E).can function as transcriptional repressors in the context
of the CD4 silencer. In Runx1F/F/Lck-Cre mice, no CD4 derepression was
observed in peripheral CD8 T lymphocytes (Figure 4A).
This suggested that Runx1 is not required for establish-Runx3 Is Required for Establishment of CD4
ment or maintenance of CD4 silencing in the cytotoxicSilencing in Mature CD8 T Cells
T cell lineage. We noticed, however, that although moreTo verify the physiological function of the Runx proteins
than 95% of the Runx1F alleles were deleted in thymo-in CD4 gene regulation, we analyzed strains of mice with
cytes from these mice, deletion was reduced to 23%mutations in each of the three Runx genes. Because
and 59% of the alleles in mature CD4 and CD8 T cells,null mutations of Runx2 and Runx3 result in neonatal
respectively (Figure 4E). This observation suggests thatlethality (Komori et al., 1997; Li et al., 2002), we analyzed
positive selection favors thymocytes with intact expres-T cells in Rag2 mutant host mice, deficient for mature
sion of Runx1, and it is hence difficult to determine if thisT lymphocytes, that had been reconstituted with fetal
molecule has a role in establishment of CD4 silencing.liver cells from Runx mutant embryos.
Runx1 is unlikely, however, to be required for mainte-Examination of Rag2/ mice reconstituted with fetal
nance of silencing, since a substantial proportion of CD8liver cells from Runx2/ mice revealed normal CD4 and
lineage T cells have both alleles inactivated. The findingCD8 expression on peripheral T cells and normal T cell
that there is little expression of Runx1 in mature T cellsnumbers (Figure 4A). In contrast, all host mice reconsti-
reinforces this conclusion.tuted with Runx3/ progenitors had CD4CD8 periph-
eral T lymphocytes (Figure 4A). In most mice, CD4 was
Runx1 Regulates CD4 Silencer Functionderepressed in a variegated manner in the absence of
in DN ThymocytesRunx3, but the degree of variegation varied in each ani-
Although inactivation of the two Runx binding sites in themal. In some cases (10%), almost all peripheral CD8
CD4 silencer resulted in partial derepression in immatureT lymphocytes had derepressed CD4 (Figure 4A, right
DN thymocytes, the absence of Runx3, which is requiredimage). Since a higher percentage of peripheral CD8
for CD4 silencing in mature CD8 lineage cells, had noT cells derepressed CD4 in host mice reconstituted with
effect on CD4 expression in the DN cells (Figure 5A).Runx3/ progenitor cells than in mice containing single
The Runx2 mutation also did not affect CD4 expressionmutations of either site 2 or 2 within the CD4 silencer
in DN thymocytes (data not shown). In contrast, in new-(Figure 2C), this result is consistent with binding of Runx
born or older Runx1F/F/Lck-Cre mice, there was an in-proteins to both of these sites.
crease in the level of CD4 in CD8 cells presumed toThe CD4CD8 peripheral T lymphocytes from
be immature DN thymocytes (Figure 5B and data notRunx3/ reconstituted mice were mature T lymphocytes
shown). We therefore examined CD4 expression on im-rather than immature DP thymocytes that had been re-
mature thymocytes from 15.5 dpc embryos, as there isleased from the thymus. They expressed CD3 or TCR
little contamination with DP cells at this early stage of(data not shown) at the same level as CD4CD8 T cells
T cell ontogeny. In Runx1F/F/Lck-Cre embryos, there wasfrom wild-type animals and at a significantly higher level
uniform derepression of CD4 in the CD8TCR thymo-than that on DP thymocytes (Figure 4B). They also had
cytes (Figure 5A). In contrast, in thymocytes from Runx3-low expression of the differentiation marker HSA, con-
deficient embryos, CD4 was not expressed (Figure 5A).sistent with their maturity (data not shown). Variegated
Notably, the level of CD4 expression in the absence ofderepression of CD4 was also observed in the thymus,
Runx1 was similar to that observed when both Runxon mature CD8 thymocytes (TCRhigh/HSAlow) from mice
sites were absent, which suggests that Runx1 plus otherreconstituted with Runx3/ progenitors (Figure 4C).
unidentified factors are required to direct full silencingThe percentage of T lymphocytes expressing CD8,
of CD4 in DN thymocytes.including those that had derepressed CD4, was reduced
in the periphery in the absence of Runx3, resulting in
an increase in the CD4:CD8 ratio to 5.8 from the normal Variegated Expression of CD8 in the Absence
of Runx1of 2.3 (Figure 4D). In the thymus, however, the CD4:CD8
ratio among mature thymocytes (TCRhigh/HSAlow) was The total number of thymocytes in Runx1F/F/Lck-Cre
mice was strikingly reduced compared to controlnot affected (Figure 4D). This discrepancy between thy-
mus and periphery suggests that Runx3 also has a role Runx//Lck-cre mice, and there was a marked increase
in the proportion of thymocytes with low or absent ex-in migration of CD8 SP thymocytes to the periphery or
in homeostasis of these cells following their export. pression of CD8 (CD4CD8lo/) compared to control
mice (Figure 5B). The CD4CD8lo/ thymocytes were im-Null mutation in Runx1 results in loss of definitive
hematopoiesis due to the absence of hematopoietic mature, by virtue of high HSA and low TCR surface
expression (Figure 5B). Reduction in the total number ofstem cells (Okuda et al., 1996). We therefore generated
mice bearing loxP-flanked Runx1 alleles (Runx1F), which thymocytes was first noted in E17.5 thymus of Runx1F-F/
Lck-Cre embryos, a stage at which the CD4CD8 sub-were bred to an Lck-cre transgenic strain to inactivate
Runx1 in early T cell progenitors (Supplemental Figure set of T cells normally predominates following rapid
expansion of cells with intact pre-TCRs (Figure 5C). The2 available at http://www.cell.com/cgi/content/full/111/
5/621/DC1). In contrast to the germline Runx1/ mice, DN thymocyte subset can be further subdivided into
four subpopulations, DN1-4, on the basis of surfacewhich display early embryonic lethality, Runx1F/F mice
developed normally, indicating that the Runx1F allele expression of CD25 and CD44. In RunxF/F/Lck-cre em-
Roles of Runx in CD4 Silencing
627
Figure 4. Runx3 Is Required for Establishing Heritable CD4 Silencing
(A) CD4 and CD8 expression profile on peripheral lymphocytes harboring mutations in each Runx gene. Peripheral lymphocytes from Runx1F/F/
Lck-Cre mice or irradiated Rag-deficient host mice reconstituted with fetal liver cells from heterozygous control and Runx2/ or Runx3/
mice were analyzed for their expression of CD4 and CD8 by flow cytometry.
(B) Normal level expression of CD3 on peripheral CD8 lymphocytes (solid line) and CD4CD8 double-positive (DP) thymocytes (dotted line)
from Rag-deficient mice reconstituted with fetal liver cells from Runx3/ mice or heterozygous control littermates.
(C) Derepression of CD4 in mature CD8-lineage thymocytes in the absence of Runx3. Thymocytes from Rag-deficient mice reconstituted with
fetal liver cells from Runx3/ or Runx3/mice were stained with anti-TCR, anti-HSA, anti-CD4, and anti-CD8 antibodies. The expression
profile of CD4 and CD8 in mature (TCRhigh/HSAlow) thymocytes is shown.
(D) Ratio of CD4 to CD8 cells in mature (TCRhigh/HSAlow) thymocytes (left) and peripheral T lymphocytes (right) from mice reconstituted with
fetal liver cells from heterozygous control or Runx3/ mice. The peripheral mature CD8 cells include the CD4CD8 subset from the mutant
mice.
(E) Efficiency of Cre-mediated deletion of the Runx F allele in mice expressing the Lck-Cre transgene. Southern blot analysis of DNA from tail
(1) or thymus (2) is shown in the left image and from purified CD4 or CD8 splenocytes is shown in the right image. Estimated percentage
of deletion is shown at the bottom of each lane. The map of the targeted locus is described in Supplemental Figure S2 (available at http://
www.cell.com/cgi/content/full/111/5/621/DC1).
bryos, there was an increase in the proportion of DN3 bryos, expressed CD4 at a level equivalent to that in
CD4CD8 DP thymocytes. This level is higher than that(CD25CD44lo) thymocytes and a corresponding reduc-
tion in DN4 cells (CD25CD44lo). This result is consistent observed in DN thymocytes when Runx1 is mutated or
when the entire CD4 silencer is deleted (Figure 5C).with impaired  selection in the absence of Runx1 (Fig-
ure 5C). Based on their level of CD4 expression and on their
kinetics of appearance in the fetal thymus, we concludeThe immature CD4CD8lo/ subpopulation, which was
first observed in E17.5 thymus of RunxF/F/Lck-cre em- that the CD4CD8lo/ thymocytes constitute a popula-
Cell
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Figure 5. Runx1 Is Required for CD4 Silencing in DN Thymocytes and for CD8 Expression in DP Thymocytes
(A) CD4 expression in DN subset thymocytes from mice with Runx site mutations in the CD4 silencer and with mutations of Runx1 and Runx3.
CD4 expression is shown in TCRCD3CD8Thy1 thymocytes. Top image: solid line, bold line, or dotted line represent CD4 expression in
wild-type mice, double Runx-site (site 2 and site 2) mutant mice, and 1–429 CD4 silencer deleted mice, respectively. In the middle and lower
images, thymocytes from 15.5 dpc Runx1F/F/Lck-Cre or Runx3/ embryos were analyzed for CD4 expression. The thin lines and bold lines
represent CD4 expression in control and mutant mice, respectively.
(B) Reduction in total thymocyte numbers and appearance of an immature CD4CD8lo/ population in Runx1F/F/Lck-Cre mice. The CD4 and
CD8 expression profile is from ungated thymocytes from four week-old-mice. Expression of TCR and HSA in the gated CD4CD8/lo
subpopulation is shown in histograms on the left (light and bold lines represent Runx1F/F and Runx1F/F/Lck-Cre, respectively).
(C) Effect of Runx1deletion on CD4 and CD8 expression during T cell ontogeny. Embryonic thymi from control (Runx1F/F) and Runx1-deleted
animals (Runx1F/F/Lck-Cre) at different stages of development are shown in upper and lower images, respectively. CD44 and CD25 expression
profiles of the CD4/loCD8 subpopulation in the thymus from 18.5 dpc embryos are shown at the right and indicate an accumulation of DN3
(CD25CD44lo) cells in the absence of Runx1. CD4 expression on all CD8-negative thymocytes from 18.5 dpc embryos is shown as a histogram
in the right image (light and bold lines represent Runx1F/F and Runx1F/F/Lck-Cre, respectively).
tion in which CD8 expression is defective. Similar popu- determine whether it has a more central role in the speci-
fication of cytotoxic T cell function. We therefore com-lations were also observed in mice with compound mu-
tations in CD8 enhancers and with impaired function of pared the ability of CD8 T cells from wild-type and
Runx3/ mice to proliferate in response to allogeneicthe BAF chromatin-remodeling complex (Chi et al., 2002;
Ellmeier et al., 2002; Garefalaki et al., 2002). The results stimulation and to kill target cells. Splenocytes (H-2b)
recovered from Rag2/ mice reconstituted with wild-thus indicate that Runx1 has several key functions in
early thymocyte differention. It is required for CD4 si- type or Runx3/ fetal liver cells were stimulated with
irradiated Balb/c splenocytes (H-2d) for five days, afterlencing in DN thymocytes, for efficient  selection of
DN thymocytes, and for upregulation of CD8 as cells which CD8 T cells were purified and mixed with 51Cr-
labeled P815 (H-2d) target cells. In contrast to controldifferentiate to the DP stage.
cells, Runx3/ CD8 T cells had a complete loss of
specific killing (Figure 6A).Runx3 Is Required for Differentiation of Functional
Cytotoxic T Cells This result could reflect a decrease in the proportion
of stimulated allo-reactive CD8 T cells rather than aTranscription factors that regulate CD4 silencing are
also good candidates to regulate specialized functions defect in effector function. We therefore examined cyto-
toxic function in a redirected lysis assay, which mea-of differentiated cytotoxic T cells. Because Runx3 was
found to be required for CD4 silencing, we wished to sures the ability of activated CD8 T cells to lyse Fc
Roles of Runx in CD4 Silencing
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Figure 6. Role of Runx3 in the Response of
Cytotoxic T Cells to Antigen
(A) Reduced allo-specific cytotoxic activity of
Runx3/ CD8 T lymphocytes. Splenocytes
derived from Rag-deficient mice reconstitu-
ted with control (squares) or Runx3 / (cir-
cles) progenitors were stimulated with alloge-
nic cells (H-2d) in a mixed lymphocytes
reaction for five days. Purified CD8 cells
were then mixed with 51Cr-labeled P815 (H-2d)
target cells. Results are shown for two inde-
pendent experiments.
(B) Normal cytotoxic activity of Runx3-defi-
cient CD8 T cells in an antibody-mediated
redirected cytotoxicity assay. Splenocytes
from mice reconstituted with control
(squares) or Runx3 / (circles) progenitors
were stimulated with immobilized anti-CD3 (5
g/ml) and anti-CD28 antibody (5 g/ml) with
IL-2 (20 units/ml) for five days. Purified CD8
cells were mixed with 51Cr-labeled target cells
expressing Fc receptor in the absence or
presence of anti-CD3 (2C11) antibody.
(C) Normal induction of perforin in CD8 T
lymphocytes from Runx3/ mice. Purified
splenic T lymphocytes were stimulated with
immobilized anti-CD3 and anti-CD28 anti-
bodies, and perforin induction was analyzed
by intracellular staining after 24 hr. Solid line,
dotted line, or bold line represent perforin lev-
els in wild-type CD8 T lymphocytes, Runx3-
deficient CD8 T lymphocytes, and wild-type
CD4 T lymphocytes.
(D) Specific reduction of proliferative re-
sponses of CD8 T cells from Runx3/ mice.
Purified CD4 or CD8 T cells from Rag-defi-
cient reconstituted mice were stimulated with
immobilized anti-CD3 antibody in combina-
tion with anti-CD28 antibody or IL-2 (left im-
age) for three days or were stimulated with
irradiated allogeneic splenocytes (right im-
age) for five days. Proliferative responses
were measured by incorporation of 3 H-thy-
midine.
receptor-expressing target cells in the presence of anti- or silenced epigenetically are poorly understood and
CD3 antibody. In this assay, cells from the mutant mice there are few examples of silencers with established in
had normal cytotoxic activity (Figure 6B). Moreover, per- vivo functions (Fisher and Merkenschlager, 2002). We
forin, which is required for effective cytolytic activity, have focused on the well-characterized CD4 silencer to
was induced in Runx3-deficient T cells as well as in identify DNA binding proteins required for its function
control cells after stimulation with anti-CD3 plus anti- in epigenetic gene regulation during T cell development
CD28 (Figure 6C). However, proliferation in response to and have shown that Runx binding sites and cognate
anti-CD3 plus anti-CD28 was severely reduced in CD8 Runt domain transcription factors are essential for CD4
T cells from Runx3/ mice compared to heterozygous silencing. The original member of this family of transcrip-
littermates (Figure 6D). There was also reduced prolifer- tion factors, runt, has been shown to be involved in
ation in response to stimulation with allogeneic spleno- negative regulation of gene expression during Drosoph-
cytes (Figure 6D). Remarkably, sorted CD4CD8 cells ila development (Wheeler et al., 2000). However, whether
from the mutant mice had normal proliferative responses Runx-mediated repression can also be maintained
to all stimuli. These results indicate that Runx3 is re- through epigenetic mechanisms has not been deter-
quired specifically for CD8 lineage T cells, but not for mined, nor have physiologically relevant targets of Runx
T helper cells, to acquire antigen responsiveness. repressive activity been previously identified in verte-
brates.
In this study, we have shown that two Runx bindingDiscussion
sites in the CD4 silencer are essential for full repression
of CD4 transcription in immature DN thymocytes andRoles of Runx in CD4 Silencing
for establishment of epigenetic silencing in CD4CD8Although it is generally accepted that gene silencing is a
cytotoxic T cells during their development in the thymus.prevalent means of gene regulation during development,
the mechanisms by which specific genes are repressed While Runx1 was shown to be required for full repression
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in DN cells, Runx3 was found to be required for estab- could be compromised chromatin modification in the
lishment of epigenetic silencing in CD8-lineage mature course of establishment of epigenetic silencing in the
thymocytes and T cells, but was not required in DN thymus, and this could result in leaky transcription in
thymocytes, despite its expression in these cells. These mature CD8 T cells. A similar low level of CD4 derepres-
results provide a unique example of a DNA binding tran- sion was observed in peripheral CD8 T lymphocytes in
scription factor required for the establishment of epige- which the entire CD4 silencer was deleted after positive
netic silencing, and also identify an in vivo target for the selection, during the establishment phase in the thymus
repressive activity of Runx proteins in vertebrates. In (Zou et al., 2001). This indicated that establishment of
addition, because of the unique properties of the CD4 epigenetic CD4 silencing requires a time window for
silencer, this developmental system provides an oppor- completion of sequential modifications of chromatin
tunity to dissect the distinct functions of Runx proteins structures, as has been shown at the mating type locus
in active transcriptional repression and in establishment of fission yeast (Nakayama et al., 2001).
of epigenetic gene silencing. The repression of CD4 at the initiation phase of estab-
In mice with Runx binding site mutations and with lishment in thymocytes undergoing positive selection
loss of function mutations of Runx1 and Runx3, there toward the cytotoxic lineage is reversible, and its mech-
were distinct patterns of CD4 derepression at different anism may hence resemble that in DN thymocytes (Zou
stages of development. These findings, and previous et al., 2001). However, it is likely that this process is
results with targeted mutations of the silencer (Taniuchi followed by recruitment of machinery that imposes
et al., 2002), are consistent with different mechanisms chromatin modifications required for heritable silencing.
of CD4 silencing at the two stages of thymocyte differen- A recent study in the Drosophila embryo has shown
tiation. We propose that Runx proteins provide different that establishment of repression of engrailed (en), a
repressive functions in immature versus mature thymo- well-characterized target gene repressed by runt, at the
cytes because of their unique requirement, despite blastoderm stage is independent of DNA binding or as-
largely overlapping expression, in these cellular subsets. sociation of runt with the corepressor Groucho, while
Mutation of both Runx binding sites resulted in uni- maintenance of transcriptional repression during germ
form but partial derepression in immature DN thymo- band extension requires both of these functions, as well
cytes. In the absence of Runx1, a similar level of dere- as Groucho and the Rpd3 histone deacetylase (Wheeler
pression was observed in DN cells (Figure 5A). Because et al., 2002). This suggests that maintenance of Runt-
both Runx2 and Runx3 are also expressed, the results directed repression involves alteration of chromatin, al-
suggest that Runx1 is the only member of the Runt though whether the repressed state of en is maintained
domain family that can repress at this stage of develop- epigenetically is not clear. Alteration of chromatin at the
ment, and that Runx1 interacts directly with the two CD4 locus, which may include histone deacetylation,
Runx binding sites in the CD4 silencer. In DN thy- methylation, and phosphorylation, is likely also initiated
mocytes, compromised function of the BAF chromatin- by Runx proteins in cells destined for the CD8 lineage,
remodeling complex resulted in partial CD4 derepres- and this is presumably followed by recruitment of epige-
sion, which was enhanced in mice harboring a mutation netic factors, such as HP-1 and polycomb group pro-
in site1 of the CD4 silencer (Chi et al., 2002). Runx1 may teins.
thus be required for recruitment of the BAF complex to It remains unclear why Runx1 and Runx3 are differen-
the CD4 locus. Runx1 has also been shown to associate tially required for CD4 silencing at different stages of
with several corepressor molecules that form com- development. It is possible that their binding to the si-
plexes with histone deacetylases (HDACs), including lencer is dependent on other factors that, in addition to
Sin3A and Groucho/TLE (Levanon et al., 1998; Lutter- the common  subunit, associate with specific Runx
bach et al., 2000). Runx1-mediated recruitment of proteins to affect their DNA binding affinity. For example,
HDACs to the CD4 silencer may thus result in reversible
at the TCR enhancer, Ets-1 augmented transcriptional
chromatin modifications, in which the BAF complex is
activity together with Runx1, but not Runx3, by coopera-
also involved, in DN thymocytes. The partial requirement
tive binding to target sites (Kim et al., 1999). Thus, thefor Runx sites and Runx1 in CD4 repression suggests
specific function of each Runx at each cis-regulatorythat other proteins, particularly those binding to sites 1
element might be regulated in part by the specific asso-and 3 (Taniuchi et al., 2002), may also recruit HDAC
ciation with other transcription factors. Within the CD4complexes and the BAF complex, resulting in some de-
silencer, there are at least two other functional sites,gree of CD4 repression in the absence of site 2/2
site 1 and site 3, which are distinct from the Runx sites.function.
Double mutations of sites 1 and 3 abolished CD4 silenc-Mutation of both Runx binding sites resulted in full
ing, suggesting that Runx sites are not functional withoutderepression of CD4 in mature CD8-lineage T cells, while
other functional sites (Taniuchi et al., 2002). It is possiblevariegated CD4 derepression was observed in Runx3/
that factors binding to these sites preferentially associ-thymocytes and T cells. This observation raises the pos-
ate with Runx1 or Runx3, thus regulating their usage.sibility that other Runx proteins can compensate at the
Each of the Runx proteins may also have unique proper-time when silencing is established. In addition, the level
ties required for interactions with repressor or epige-of derepressed CD4 in Runx3-deficient mice was not as
netic machinery.high as in mice with mutations in both Runx binding
sites. This suggests that residual binding of factors to
Roles of Runx in T Cell Differentiationsites 2 and 2, in cells in which epigenetic silencing
Since Runx3 is specifically required for lineage-specifichad failed to be established, can reduce the level of
expression. Alternatively, in the absence of Runx3, there CD4 silencing, this transcription factor could potentially
Roles of Runx in CD4 Silencing
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be a key molecule involved in regulating lineage specific- nisch, 1998; Tilghman, 1999). As Runx proteins have
been shown to have pivotal roles in multiple develop-ity. Indeed, in its absence, peripheral CD8 T cells were
markedly reduced in number and had a severe prolifera- mental processes across species (Canon and Banerjee,
2000; Karsenty, 2000; Tracey and Speck, 2000), thesetive defect. This phenotype is due to the requirement
for Runx3 activity on unknown target genes rather than factors may regulate cell fate determination at develop-
mental branch points, in part through epigenetic activa-on CD4, since CD8 T cells displayed normal differentia-
tion and function in mice in which the CD4 silencer tion or silencing of target genes.
Mutations of RUNX genes have been shown to bewas deleted (Zou et al., 2001). The results suggest a
requirement for Runx3 in the generation and/or the sur- involved in carcinogenesis: RUNX1 in acute myeloid leu-
kemia (Miyoshi et al., 1991; Osato et al., 1999) andvival of the cytotoxic T cell population. In light of the
function of Runx3 in epigenetic regulation of CD4, it RUNX3 in gastric cancer (Li et al., 2002). It is possible
that Runx factors induce epigenetic silencing of theirwill be interesting to determine whether the defect in
cytotoxic T cells is also due to loss of a heritably main- target oncogenes, so that loss of Runx function results in
persistent oncogene activation. In this sense, temporaltained function in these cells.
We were unable to detect a significant difference in activation of Runx would be sufficient to permanently
inactivate target oncogenes and repress carcinogene-Runx3 transcript levels between cells of the helper and
cytotoxic lineage, indicating that expression of Runx sis, as temporal inactivation of Myc resulted in the sus-
tained loss of a neoplastic phenotype (Jain et al., 2002).genes is not sufficient to induce CD4 silencing. It is
possible that molecules associated with Runx3 or post- Further studies to understand the molecular mecha-
nisms of epigenetic gene regulation by Runx shouldtranslational modifications of Runx3 regulate lineage
specificity of CD4 gene silencing and CTL function. For provide insight into how cells fix their identity during
development and in tumorigenesis.example, phosphorylation, which has been reported for
Runx1 and Runx2 in response to external stimuli, could
Experimental Proceduresbe differentially regulated in T cell subsets (Selvamuru-
gan et al., 2000; Tanaka et al., 1996; Wee et al., 2002).
In Vitro Transient Transfection Assay
Due to loss of definitive hematopoiesis in the absence For construction of CAT reporter plasmids, mutant CD4 silencer
of Runx1, it has not been possible to examine its require- fragments were generated by PCR with appropriate primers, and
DNA sequence of these fragments was confirmed. Three copies ofment for T cell development. By using Cre-mediated
each CD4 silencer fragment were placed in the polylinker site at therecombination to inactivate Runx1 in thymocytes, we
5 end of pCD4/CD4ECAT vector (Sawada and Littman, 1991). Theshowed that it is required both for gene activation (CD8)
cDNAs encoding GAL4-DB, Runx1, Runx3, and the Runx1 Runtand for gene repression (CD4) in early T cell develop-
domain were obtained by PCR with appropriate primers. DNA se-
ment. In addition, impaired  selection observed in quence of these PCR products was confirmed. The cDNAs of GAL4-
Runx1F/F/Lck-Cre mice is consistent with inefficient re- DB, GAL4-Runx1, GAL4-Runx3, Runx1, Runx3, or the Runx1 Runt
domain were placed at the cloning sites of pcDNA3.1 vector (In-arrangement and activation of TCR genes (I.T., unpub-
vitrogen) to generate expression vectors. Transfections of 1200Mlished data).
cells and assays for CAT activity were performed as described pre-Inefficient upregulation of CD8 during differentiation
viously (Taniuchi et al., 2002).of DP thymocytes was observed in three mutant strains:
mice deficient for Runx1, mice harboring compound mu- Antibodies and Flow Cytometry Analyses
tations in CD8 enhancers, and mice with impaired func- All the antibodies used for flow cytometry were purchased from
Caltag or Pharmingen unless otherwise mentioned. Anti-mouse per-tion of the BAF chromatin remodeling complex (Chi et
forin antibody was from Kamiya Biomedical. Intracellular stainingal., 2002; Ellmeier et al., 2002; Garefalaki et al., 2002).
was performed as described previously (Opferman et al., 1999). CellsVarious degrees of CD8 expression in cells containing
stained with fluorescent antibodies were analyzed using FACScan orthe same mutation in cis-regulatory regions suggested
FACs Calibur flow cytometers and CELL Quest software (BD).
stochastic “on” or “off” selection in each cell and
involvement of epigenetic mechanisms in maintenance Mice
For targeted mutagenesis of Runx binding sites in the CD4 silencer,of active transcription. A potential function of Runx1
targeting vectors were constructed as described (Taniuchi et al.,may be to guide the BAF chromatin-remodeling complex
2002). Runx2- and Runx3-deficient mice were described previouslyto both the CD8 and CD4 loci, to initiate chromatin open-
(Komori et al., 1997; Li et al., 2002). For analysis of T lymphopoiesising for subsequent recruitment of coactivators or core-
in adults, 1–3 	 106 fetal liver cells from mutant mice were injected
pressors. The choice of the coregulatory molecules, intravenously into sublethally irradiated (5 Gy) Rag2-deficient mice
which is governed by the combination of transcription (Jackson Laboratory). Thymocytes or T lymphocytes in the reconsti-
tuted host mice were analyzed 8 weeks after transplantation.factors binding to each locus, would determine if genes
To generate mice harboring a Runx1 allele flanked by loxP sites,are repressed or activated.
a targeting vector was constructed with a 5.2 kb XhoI-BamHI 5
homology region, a 1.3 kb PCR-generated 3 homology region, and
Epigenetic Gene Regulation by Runx a 4.0 kb BamHI-XhoI fragment in which exon 4 was flanked by loxP
Our results show that a DNA sequence-specific tran- sequences. 30 g of NotI-linearized vector was electroporated into
E14 embryonic stem cells and G418/ganciclovir double-resistantscription factor, in this case Runx3, can have an essen-
colonies were screened for homologous recombination by PCR.tial role in the establishment of developmental stage-
Positive clones were subjected to Southern analysis to confirm inte-specific and lineage-specific epigenetic gene silencing
gration of the third loxP site. The positive clones were transientlyin vertebrates. Although X inactivation and gene im-
transfected with the Cre recombinase expression vector pMC-Cre
printing are well-characterized examples of epigenetic (Gu et al., 1993) to delete the neomycin resistance cassette (neor ).
gene silencing, these are established early in em- After deletion of neor, ES cells were injected into C57BL6 blastocysts
to generate chimeric mice.bryogenesis and are initiated by RNA (Panning and Jae-
Cell
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Yeast One-Hybrid Screening Received: September 12, 2002
Revised: October 17, 2002Three copies of the wild-type CD4 silencer fragment (sequence
131–265) were cloned into multiple cloning sites of the pHISi-1 or
pLacZi vectors (Clontech) to make reporter gene constructs. The References
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